Johnson & Johnson's Official Statement in Response to Today's Verdict in St. Louis Trial
July 12 2018 - 7:57PM
PR Newswire (US)
NEW BRUNSWICK,
N.J., July 12,
2018 /PRNewswire/ -- Johnson & Johnson
(NYSE: JNJ) issued the following statement regarding today's
verdict in the St. Louis
court.
"Johnson & Johnson is deeply disappointed in the
verdict, which was the product of a fundamentally unfair process
that allowed plaintiffs to present a group of 22 women, most of
whom had no connection to Missouri, in a single case all alleging that
they developed ovarian cancer. The result of the verdict, which
awarded the exact same amounts to all plaintiffs irrespective of
their individual facts, and differences in applicable law, reflects
that the evidence in the case was simply overwhelmed by the
prejudice of this type of proceeding. Johnson & Johnson
remains confident that its products do not contain asbestos and do
not cause ovarian cancer and intends to pursue all available
appellate remedies. Every verdict against Johnson &
Johnson in this court that has gone through the appeals process has
been reversed and the multiple errors present in this trial were
worse than those in the prior trials which have been
reversed."
View original content with
multimedia:http://www.prnewswire.com/news-releases/johnson--johnsons-official-statement-in-response-to-todays-verdict-in-st-louis-trial-300680519.html
SOURCE Johnson & Johnson
Copyright 2018 PR Newswire
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Aug 2024 to Sep 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Sep 2023 to Sep 2024